U.S. Telemedicine Market Size, Share & Forecast 2026–2032

ID: MR-11804 | Published: November 2026
Download PDF Sample

Report Highlights

  • ✓Country: United States
  • ✓Market: Telemedicine
  • ✓Market Size 2024: USD 62.4 billion
  • ✓Market Size 2032: USD 165.8 billion
  • ✓CAGR: 13.0%
  • ✓Base Year: 2025
  • ✓Forecast Period: 2026–2032
Market Growth Chart
Want Detailed Insights - Download Sample
Analyst Findings and Recommendations
FINDING 01
Medicare Advantage Drives Volume: Medicare Advantage plans, covering over 32 million enrollees, are bundling virtual visits into supplemental benefits. This shifts pricing power to plan sponsors; Teladoc Health and Amwell now negotiate per-member-per-month contracts instead of per-visit fees.
FINDING 02
Telehealth Policy Will Not Stabilize: The consensus view holds that Congress will make Medicare telehealth flexibilities permanent. Repeated short-term extensions and brief lapses since 2020 show otherwise, so durable growth will come from commercial payers and Medicare Advantage, not Medicare fee-for-service.
ANALYST RECOMMENDATION

Analyst Recommendation — Lock Multistate Licensure Now: Entrants should join the Interstate Medical Licensure Compact and secure multistate licenses before Q2 2026, then pursue Medicare Advantage contracts in high-enrollment states. Scale depends on clearing state licensure and parity rules, which differ across all 50 states.

Telemedicine in the U.S.: Market Overview

The U.S. telemedicine market was valued at USD 62.4 billion in 2024 and is forecast to reach USD 165.8 billion by 2032, growing at a 13.0% CAGR. Unlike most global markets, it is shaped less by consumer device adoption than by payer reimbursement rules. Medicare, Medicaid, and commercial insurers set the economics of each visit, so the market follows policy decisions more closely than technology cycles. Commercial parity laws now exist in most states, which requires private payers to reimburse virtual visits at rates close to in-person care.

Market structure is also unusual. Health systems such as Mayo Clinic and Kaiser Permanente run in-house virtual programs alongside venture-backed platforms like Teladoc Health and Amwell. The result is a hybrid market where integrated delivery networks compete with standalone consumer platforms for the same patients, and where most revenue still comes from scheduled video visits rather than asynchronous care.

Growth Drivers for Telemedicine in the U.S.

Three country-specific drivers sustain demand. First, Medicare Advantage enrollment has passed 32 million, and CMS permits plans to offer virtual visits as supplemental benefits, which pushes plan sponsors to contract with platforms such as Teladoc Health and Amwell. Second, more than 60 million Americans are aged 65 or older, and chronic disease management is increasingly delivered remotely through primary care practices.

Third, CMS has paid for remote patient monitoring under CPT codes 99453, 99454, 99457, and 99458 since 2019, and behavioral health demand keeps rising as Talkspace and Cerebral serve patients who previously lacked psychiatric access. Medicare mental health telehealth provisions also allow beneficiaries to receive therapy at home, which expands the addressable patient base materially.

Market Restraints and Entry Barriers

Licensure remains the central barrier. Clinicians must hold a license in each state where the patient is located, and while the Interstate Medical Licensure Compact accelerates multistate licensing across more than 40 member states, it does not eliminate state-by-state application costs. Corporate practice of medicine doctrines in states such as California and New York also restrict non-physician-owned platforms from employing clinicians directly.

Reimbursement fragmentation is the second barrier. Medicare has required telehealth visits to originate from specified sites, and its flexibilities have lapsed and been reinstated repeatedly, forcing providers to plan around uncertain payment. Commercial pricing is controlled by incumbent integrated networks such as UnitedHealth Group and Cigna's Evernorth, which hold significant contracting leverage. DEA controlled-substance prescribing rules add a further compliance layer.

Market Opportunities in the U.S.

Remote patient monitoring offers the nearest entry point. Existing Medicare CPT codes reimburse device-based monitoring for chronic conditions, and more than 60 percent of U.S. adults live with at least one chronic condition, according to CDC estimates. We estimate the addressable pool across Medicare Advantage and commercial plans at roughly USD 12 billion in 2025, with the segment expanding fastest among heart failure and diabetes cohorts.

Behavioral health and Medicaid managed care present the second opportunity. Plans in states such as Texas and Florida face severe psychiatrist shortages, and we estimate telepsychiatry contracts with these plans could address USD 4 billion in annual spend by 2027. Employers offering virtual-first benefits through carriers such as Elevance Health also represent a sizable channel for entrants with proven outcomes data.

Long-Term Outlook for Telemedicine in the U.S.

By 2032 the U.S. telemedicine market is projected to reach USD 165.8 billion, with hybrid care models becoming the default for primary and behavioral care. Virtual visits will be integrated into health system operating models rather than sold as standalone products, and remote monitoring will be embedded within Medicare Advantage risk contracts across most large plan sponsors.

Policy stability will determine the pace of expansion. If Congress converts Medicare flexibilities into permanent law and DEA finalizes its special registration framework, growth will move toward the upper end of the forecast range. Failure to achieve either outcome will keep platforms dependent on commercial and Medicare Advantage payers, favoring consolidated operators such as Teladoc Health and Amwell.

Market at a Glance

MetricValue
Market Size 2024USD 62.4 billion
Market Size 2032USD 165.8 billion
Growth Rate (CAGR)13.0%
Most Critical Decision FactorDurability of Medicare and commercial reimbursement policy
Largest RegionSouth (largest patient population)
Competitive StructureFragmented, with consolidation among platforms and health system programs

Leading Market Participants

  • Teladoc Health
  • Amwell
  • Talkspace
  • Hims & Hers Health
  • LifeMD
  • MDLIVE
  • Included Health
  • Virta Health
  • Doctor On Demand
  • Cerebral

Regulatory and Policy Environment

Medicare telehealth is governed by Section 1834(m) of the Social Security Act, implemented through the annual Medicare Physician Fee Schedule final rule issued by CMS, which takes effect January 1 each year. The Consolidated Appropriations Act, 2021 and subsequent continuing resolutions have extended Medicare flexibilities in short increments. DEA telemedicine controlled-substance flexibilities, first issued during the COVID-19 public health emergency, have been extended through successive annual orders while the DEA special registration rule remains pending.

Privacy compliance falls under HIPAA, administered by the HHS Office for Civil Rights, with security obligations set by the HIPAA Security Rule. The FCC Rural Health Care Program, with an annual funding cap above USD 500 million, subsidizes broadband for eligible rural clinics. State parity statutes and medical licensing boards add further requirements, and FDA device regulations under 21 CFR Part 820 apply to connected monitoring equipment. Entrants should budget six to twelve months for state licensure and HIPAA risk assessments before launch.

Frequently Asked Questions

No, clinicians generally need a license in each state where the patient is located. The Interstate Medical Licensure Compact streamlines applications but does not remove state-level requirements.
Medicare Advantage plans buy virtual care through per-member contracts, so entrants should target plan sponsors early. Securing one large plan contract can deliver more volume than years of direct-to-consumer marketing.
Congress has extended them repeatedly since 2020, with several brief lapses along the way. Operators should plan financial models around short-term funding cycles.
The Drug Enforcement Administration governs controlled-substance prescribing via telehealth. Its flexibilities have been extended through annual orders while the special registration rule remains pending.
Remote patient monitoring offers the fastest entry because existing Medicare CPT codes already reimburse it. Operators can build a chronic care program on these codes before pursuing more complex service lines.

Market Segmentation

By Service Type
  • Synchronous Video Consultations
  • Remote Patient Monitoring
  • Store-and-Forward Services
  • Mental Health Telehealth
  • Others
By End User
  • Hospitals and Health Systems
  • Health Plans and Payers
  • Employers
  • Individual Patients
  • Others
By Payment Model
  • Fee-for-Service Reimbursement
  • Per-Member-Per-Month Contracts
  • Direct-to-Consumer Cash Pay
  • Employer-Sponsored Benefits

Table of Contents

Chapter 01 Methodology and Scope
1.1 Research Methodology
1.2 Scope and Definitions
1.3 Data Sources
Chapter 02 Executive Summary
2.1 Report Highlights
2.2 Market Size and Forecast 2024-2032
Chapter 03 U.S. Telemedicine - Market Analysis
3.1 Market Overview
3.2 Growth Drivers
3.3 Restraints
3.4 Opportunities
Chapter 04 Service Type Insights
4.1 Synchronous Video Consultations
4.2 Remote Patient Monitoring
4.3 Store-and-Forward Services
4.4 Mental Health Telehealth
4.5 Others
Chapter 05 End User Insights
5.1 Hospitals and Health Systems
5.2 Health Plans and Payers
5.3 Employers
5.4 Individual Patients
5.5 Others
Chapter 06 Competitive Landscape
6.1 Market Players
6.2 Leading Market Participants
6.2.1 Teladoc Health
6.2.2 Amwell
6.2.3 Talkspace
6.2.4 Hims & Hers Health
6.2.5 LifeMD
6.2.6 MDLIVE
6.2.7 Included Health
6.2.8 Virta Health
6.2.9 Doctor On Demand
6.2.10 Cerebral
6.3 Regulatory Environment
6.4 Outlook

Research Framework and Methodological Approach

Information
Procurement

Information
Analysis

Market Formulation
& Validation

Overview of Our Research Process

MarketsNXT follows a structured, multi-stage research framework designed to ensure accuracy, reliability, and strategic relevance of every published study. Our methodology integrates globally accepted research standards with industry best practices in data collection, modeling, verification, and insight generation.

1. Data Acquisition Strategy

Robust data collection is the foundation of our analytical process. MarketsNXT employs a layered sourcing model.

Secondary Research
  • Company annual reports & SEC filings
  • Industry association publications
  • Technical journals & white papers
  • Government databases (World Bank, OECD)
  • Paid commercial databases
Primary Research
  • KOL Interviews (CEOs, Marketing Heads)
  • Surveys with industry participants
  • Distributor & supplier discussions
  • End-user feedback loops
  • Questionnaires for gap analysis

Analytical Modeling and Insight Development

After collection, datasets are processed and interpreted using multiple analytical techniques to identify baseline market values, demand patterns, growth drivers, constraints, and opportunity clusters.

2. Market Estimation Techniques

MarketsNXT applies multiple estimation pathways to strengthen forecast accuracy.

Bottom-up Approach

Country Level Market Size
Regional Market Size
Global Market Size

Aggregating granular demand data from country level to derive global figures.

Top-down Approach

Parent Market Size
Target Market Share
Segmented Market Size

Breaking down the parent industry market to identify the target serviceable market.

Supply Chain Anchored Forecasting

MarketsNXT integrates value chain intelligence into its forecasting structure to ensure commercial realism and operational alignment.

Supply-Side Evaluation

Revenue and capacity estimates are developed through company financial reviews, product portfolio mapping, benchmarking of competitive positioning, and commercialization tracking.

3. Market Engineering & Validation

Market engineering involves the triangulation of data from multiple sources to minimize errors.

01 Data Mining

Extensive gathering of raw data.

02 Analysis

Statistical regression & trend analysis.

03 Validation

Cross-verification with experts.

04 Final Output

Publication of market study.

Client-Centric Research Delivery

MarketsNXT positions research delivery as a collaborative engagement rather than a static information transfer. Analysts work with clients to clarify objectives, interpret findings, and connect insights to strategic decisions.